ClinicalTrials.gg
RecruitingNCT07472088Updated Oct 8, 2026

Assessing the Association Between WBCT PFJ Morphological Metrics and Knee Symptoms

An observational study in Knee Osteoarthritis and Patellofemoral Pain (PFPS), sponsored by University of Kansas Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by University of Kansas Medical Center · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Updated Oct 8, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
36
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 796 studies in Osteoarthritis, Knee with a site in United States — 109 open to participants now, 152 under way, 15 of them phase 3. Osteoarthritis, Knee · United States.

Planned enrollment
82nd of 101
36 · median 100
Started
2026
with 29 others
Observational
101 of 796
18 open now
Primary completion
2026-11
later than 39 of 151 live
Registered
773rd of 796
by date

Among the 796 studies in Osteoarthritis, Knee with a site in United States, this one is the 82nd largest by planned enrollment of the 101 observational ones that give a count, is one of 30 that started in 2026, is one of 101 observational ones, reaches primary completion later than 39 of the 151 other live ones, and was the 773rd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

109 of the 796 studies in Osteoarthritis, Knee with a site in United States are open now. Recruiting first, the newest first:

103 more — sign in →

All 109 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 796 studies in Osteoarthritis, Knee with a site in United States, or all of them as a file.
02

Study summary

Patellofemoral joint (PFJ) pain is a common, often chronic, aching pain behind or around the kneecap, frequently called "runner's knee". It occurs when the kneecap does not glide smoothly over the thigh bone, often due to muscle weakness or overuse. It makes sitting for long periods, climbing stairs, or kneeling painful.

Symptomatic knee osteoarthritis (OA) is a common, long-term condition where the protective cartilage in the knee joint wears away, causing the bones to rub together, leading to daily pain and stiffness. In simple terms, it is a "wear-and-tear" disease of the entire joint that makes walking, climbing stairs, or bending the knee difficult.

The PFJ is where the patella (kneecap) meets the femoral trochlea (front part of the lower thigh bone) at the front of the knee. Patellar tracking refers to the movement of the patella that begins to engage in the distal femoral trochlear groove (smooth, U-shaped groove at the bottom of the thigh bone).

By doing this study, we hope to advance clinical knowledge of the PTJ features in a more natural position by using weight-bearing computed tomography (WBCT) images while the leg is straight and slightly bent. Determining links between specific knee symptoms and the PTJ structure on WBCT images could enable providers to effectively target the underlying causes and to develop targeted treatments.

Read the detailed description

The patellofemoral joint (PFJ) is the articulation where the patella meets the femoral trochlea at the front of the knee. Patellar tracking refers to the movement of the patella that begins to engage in the distal femoral trochlear groove.

The proposed research will advance clinical knowledge of patellofemoral joint features in a more physiological position by using weight-bearing computed tomography (WBCT) images at 0° and 20° of knee flexion. Determining associations between specific knee symptoms and patellofemoral joint structural metrics on WBCT images could enable providers to effectively target the underlying causes and to develop targeted treatments.

PFJ features have become a significant area of interest, and numerous studies have been conducted to understand morphological characteristics, as it is the most common site associated with many knee symptoms and is a frequent location of early knee osteoarthritis (OA). There is growing evidence indicating that patellofemoral OA contributes to knee pain and functional limitations independent of tibiofemoral OA, and that the etiology and management may differ. A key factor in the risk profile for PFJ dysfunction may be malalignment of the patella with the femoral trochlea and subsequent abnormal tracking in the groove, leading to abnormal loading and wear of PFJ subchondral bone, microtearing of the lateral retinaculum, or irritation of the synovium, one of the most painful structures in the knee.

Quantifying patellofemoral alignment is an important aspect in assessing knee health, particularly in conditions that affect the PFJ, such as patellar instability, OA, or patellofemoral pain syndrome. There is no consensus on PFJ imaging position, knee flexion angle, joint position (e.g. stabilized or free), weight-bearing status, or beam angulation. However, the introduction of weight-bearing CT (WBCT) provides the ability to acquire 3D imaging of the PFJ under functionally loaded conditions. Using WBCT offers a unique advantage in this context because it allows for the evaluation of the knee in a loaded position, closely simulating the conditions under which the joint normally operates during activities like walking, running, and jumping, and under conditions in which the PFJ is symptomatic.

WBCT provides a three-dimensional view of the patellofemoral joint, allowing for the accurate measurement of various alignment parameters. These measurements may include the TT-TG, reTFR, patellar tilt angle, patellar height, and congruence angle. By analyzing these parameters, clinicians can gain insights into the alignment and positioning of the patella relative to the femur and the tibia.

Rationale:

WBCT can give us a better understanding of the patellofemoral joint in a loaded configuration in which the joint normally works during activities like walking, running, and jumping. This three-dimensional view will allow us to measure alignment parameters in a more functional position. This imaging technique is particularly valuable because it demonstrates the influence of factors such as muscle contractions or soft tissue conditions, the lack of which may distort results in non-weight-bearing assessments. Determining the extent to which these parameters are associated with knee symptoms will help to guide treatment decisions and improve clinical outcomes for patients with knee disorders.

03

Conditions studied

  • Knee Osteoarthritis
  • Patellofemoral Pain (PFPS)

Keywords

  • patellofemoral joint
  • knee osteoarthritis
  • weight-bearing CT (WBCT)
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Voluntary participants who consented to be contacted for research

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18
  • Knee pain, falling into either of the two groups, i.e., PFJ pain (pain only in the anterior region of the knee) or symptomatic knee OA (pain in any other area of the knee, including the anterior region)

Exclusion criteria

Exclusion Criteria:

  • Bilateral total knee arthroplasty
  • Pregnant
  • Unable to stand safely for 2 minutes with support
  • Any condition that the investigator identifies as inappropriate for participation (e.g., unable to participant in consent process, unsafe to stand on WBCT platform, etc.)
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
36 participants (estimated)
Patient registry
No

Groups and cohorts

  • PFJ pain

    Participants experiencing recurrent, atraumatic patella dislocation, knee pain isolated to the anterior region, or PFPS (pain around the patella, exacerbated by prolonged positioning or ascending/descending stairs)

    Radiation: WBCT

  • Symptomatic knee OA

    Participants experiencing pain in any other area of the knee, including the anterior region in combination with other regions

    Radiation: WBCT

Interventions

  • RadiationWBCT

    Images of the knee will be acquired using a WBCT, which provides a three-dimensional view of the patellofemoral joint in a loaded configuration.

06

What researchers measure

Primary outcomes

  1. TT-TG

    Tibial Tuberosity - Trochlear Grove (TT-TG) will be measured on 3D WBCT knee images acquired at 0° and 20±5° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

  2. reTRF

    Relative external tibiofemoral rotation (reTFR) will be measured on 3D WBCT knee images acquired at 0° and 20±5° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

  3. Congruence Angle

    Congruence angle will be measured on 3D WBCT knee images acquired at 20±5° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

Secondary outcomes

  1. PTA

    Patellar tilt angle (PTA) will be measured on 3D WBCT knee images acquired at 0° and 20±5° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

  2. Bisect Offset

    Bisect offset will be measured on 3D WBCT knee images acquired at 0° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

  3. Patellar Height

    Patellar height will be measured on 3D WBCT knee images acquired at 0° and 20±5° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

Other outcomes

  1. Patellar tilt

    The angle between the line connecting the most posterior points of femoral condyles and the patella axis through the medial and lateral borders will be measured on WBCT acquired at 0° of knee flexion.

    Time frame: From enrollment to end of study (1 day)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Sieberer JM, Park N, Desroches S, Brennan K, Rancu A, McGinley B, Manafzadeh AR, Segal NA, Felson D, Tommasini SM, Wiznia DH, Fulkerson JP. Breaking down tibial tuberosity to trochlear groove distance into two components to enable patient-specific treatment strategies. J ISAKOS. 2026 Feb;16:101025. doi: 10.1016/j.jisako.2025.101025. Epub 2025 Oct 30. PubMed 41173215 ↗
  • Park N, Sieberer JM, McGinley B, Manafzadeh AR, Lynch J, Segal NA, Lewis CE, Guermazi A, Roemer FW, Stefanik J, Felson DT, Fulkerson JP. Measures of Patellofemoral Morphology Predict the Risk of Local Cartilage Damage Progression: A Yale/MOST Collaborative Study. Am J Sports Med. 2025 Oct;53(12):2881-2888. doi: 10.1177/03635465251367716. Epub 2025 Sep 12. PubMed 40938089 ↗
  • Park N, Sieberer J, Manafzadeh A, Hackbarth RM, Desroches S, Ghankot R, Lynch J, Segal NA, Stefanik J, Felson D, Fulkerson JP. Semiautomated Three-Dimensional Landmark Placement on Knee Models Is a Reliable Method to Describe Bone Shape and Alignment. Arthrosc Sports Med Rehabil. 2024 Nov 5;7(2):101036. doi: 10.1016/j.asmr.2024.101036. eCollection 2025 Apr. PubMed 40297085 ↗
  • Yu KE, Beitler B, Cooperman DR, Frumberg D, Schneble C, McLaughlin W, Fulkerson JP. Three-Dimensional Reproductions for Surgical Decision-Making in the Treatment of Recurrent Patella Dislocation. Arthrosc Tech. 2023 May 1;12(6):e807-e811. doi: 10.1016/j.eats.2023.02.010. eCollection 2023 Jun. PubMed 37424639 ↗
  • Sieberer JM, Park N, Manafzadeh AR, Desroches ST, Brennan K, McDonald C, Tommasini SM, Wiznia DH, Fulkerson JP. Visualization of Trochlear Dysplasia Using 3-Dimensional Curvature Analysis in Patients With Patellar Instability Facilitates Understanding and Improves the Reliability of the Entry Point to Trochlea Groove Angle. Arthrosc Sports Med Rehabil. 2024 Sep 26;7(1):101010. doi: 10.1016/j.asmr.2024.101010. eCollection 2025 Feb. PubMed 40041820 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Apr 2026 (actual). Primary completion is estimated for Nov 2026, 7 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 8, 2026: primary completion Aug 2026 → Nov 2026 and completion Aug 2026 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2026
First posted
Mar 16, 2026
StartActual
Apr 29, 2026
Primary completionEst.
Nov 2026was Aug 2026
CompletionEst.
Nov 2026was Aug 2026
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 2026→Nov 2026
Oct 8, 2026
Study completion
Aug 2026→Nov 2026
Oct 8, 2026
Contact
Study contact's phone or email changed: •••0961→•••0958. See the current contact
Oct 8, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • University of Kansas Medical Center · Kansas City, United StatesContact •••0961→•••0958
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    Primary completion Aug 2026→Nov 2026
    Study completion Aug 2026→Nov 2026
    Contact Study contact's phone or email changed: •••0961→•••0958. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • University of Kansas Medical Center · Kansas City, United StatesContact •••0961→•••0958

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07472088
Responsible party
Neil Segal, MD, MS (Director of Clinical Research, University of Kansas Medical Center) — Principal investigator
First posted
Mar 16, 2026
Start date
Apr 29, 2026
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Oct 8, 2026

Study contacts

Jessica Lee, PhD
Contact
jlee33@kumc.edu
913-574-0958
Yashaf Zaheer, MD
Contact
yzaheer@kumc.edu
Neil A Segal, MD, MS
principal investigator · University of Kansas Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion